EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High‐Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression

Hui Liu, Jie Zhou, Yunxia Xiao, Yuming Zheng, Liyao Yu, Dirong Dong, Yanqing Shen, Wen Zhang, Wei Guo, Rui Tian, Xun Tian, Xia Huang und 3 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Hui Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital Northwest University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Papillomavirus Infections, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2025ZD0544102), Xi'an People's Hospital (Xi'an Four….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐risk human papillomavirus (hrHPV) infection is the primary cause of cervical cancer. However, hrHPV testing lacks specificity in detecting neoplastic changes. This study explored the utility of quantitative methylated HPV DNA markers for precise detection of cervical lesions. Using hybridization capture‐based bisulfite sequencing, we analyzed genome‐wide HPV methylation patterns. The study included a training cohort of 60 cervical exfoliated cell samples and a validation cohort of 29 samples. Analysis of 112 CpG sites across the HPV genome revealed that genome‐wide HPV16 methylation levels correlated with disease progression. Squamous cell carcinoma (SCC) showed 1.4‐fold higher methylation levels compared to normal tissue ( p = 0.0032). Progressive methylation increases in the E5‐α and L2 genes were observed across the spectrum of cervical lesion severity, from normal tissue through high‐grade squamous intraepithelial lesion (HSIL) to SCC. Intersection analysis of differentially methylated CpG sites between HSIL vs Normal and SCC vs Normal identified 16 consistently hypermethylated CpG sites in the E5‐α, E7, L2, and L1 genes, distinguishing both HSIL and SCC from normal tissue. This pilot study identifies a five‐CpG methylation panel (E5‐α_3887, E5‐α_3941, E7_701, L2_4441, and L2_5128) as promising triage biomarkers for HPV16‐positive women, achieving high discriminatory performance (AUC = 0.919 in a validation cohort) for detecting cervical lesions. This genome‐wide capture sequencing identified novel HPV16 methylation markers that distinguish cervical lesions from normal tissue, supporting the feasibility of HPV methylation‐based triage for HPV‐positive women in cervical cancer screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationUterine Cervical NeoplasmsPapillomavirus InfectionsHigh-Throughput Nucleotide SequencingHuman papillomavirus 16PapillomaviridaeHumansFemaleMiddle AgedAdultDisease ProgressionCarcinoma, Squamous CellPilot ProjectsDNA, ViralCpG IslandsUterine Cervical DysplasiaAged

Stichwörter der Autor:innen

HPV methylationcervical cancercervical intraepithelial neoplasiahuman papillomavirus

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Pathology, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital Northwest University, Xi'an, Shaanxi, China.
  • Department of Gynecology, Yue Bei People's Hospital, Guangdong, Shaoguan, China.
  • Department of Gynecologic Oncology, Women and Children's Hospital Affiliated to Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Health Management Center, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Obstetrics and Gynecology, Academician expert workstation, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Generulor Co. Ltd., Zhuhai, Guangdong, China.

Förderung

  • This study was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2025ZD0544102), Xi'an People's Hospital (Xi'an Four…

Zitieren

APA

Liu, H., Zhou, J., Xiao, Y., Zheng, Y., Yu, L., Dong, D., Shen, Y., Zhang, W., Guo, W., Tian, R., Tian, X., Huang, X., Hu, Z., Sun, L., & Cao, C. (2025). High‐Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression. Journal of Medical Virology. https://doi.org/10.1002/jmv.70739

Vancouver

Liu H, Zhou J, Xiao Y, Zheng Y, Yu L, Dong D, et al. High‐Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression. Journal of Medical Virology. 2025. doi:10.1002/jmv.70739

BibTeX
@article{Liu2025,
  author = {Liu, Hui and Zhou, Jie and Xiao, Yunxia and Zheng, Yuming and Yu, Liyao and Dong, Dirong and Shen, Yanqing and Zhang, Wen and Guo, Wei and Tian, Rui and Tian, Xun and Huang, Xia and Hu, Zheng and Sun, Lili and Cao, Chen},
  title = {High‐Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70739}
}
Kostenlos starten →